Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (vol 101, pg 8705, 2004)

被引:6
作者
Bielekova, B
Richert, N
Howard, T
Blevins, G
Markovic-Plese, S
McCartin, J
Würfel, J
Ohayon, J
Waldmann, TA
McFarland, HF
Martin, R
机构
[1] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[2] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA
[3] NIH, Expt Neuroimaging Sect, Lab Diagnost Radiol Res, Bethesda, MD 20892 USA
[4] Humboldt Univ, Inst Neuroimmunol, Charite, D-10117 Berlin, Germany
[5] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1073/pnas.0404694101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:17565 / 17565
页数:1
相关论文
共 1 条
  • [1] Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
    Bielekova, B
    Richert, N
    Howard, T
    Blevins, G
    Markovic-Plese, S
    McCartin, J
    Würfel, J
    Ohayon, J
    Waidmann, TA
    McFarland, HF
    Martin, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (23) : 8705 - 8708